Results 131 to 140 of about 27,788 (240)

Malnutrition and diabetes outcomes 12 months after total pancreatectomy: A descriptive cohort study

open access: yesJournal of Parenteral and Enteral Nutrition, Volume 50, Issue 4, Page 573-581, May 2026.
Abstract Background Total pancreatectomy is a rare but increasingly performed surgical procedure that systematically induces endocrine and exocrine pancreatic insufficiency. Data on long‐term nutritional outcomes after this surgery are limited. The objective of this study was to assess the prevalence of malnutrition at 3 months and 12 months after ...
Ibrahima Maiga   +5 more
wiley   +1 more source

Environmental Enrofloxacin Exposure as a Modifiable Driver of Mitochondria‐Mediated Intestinal Aging and Barrier Dysfunction

open access: yesAging Cell, Volume 25, Issue 5, May 2026.
Environmentally relevant enrofloxacin accelerates intestinal aging by impairing epithelial mitochondrial function, disrupting barrier integrity, and reshaping the gut microbiota. Mitochondrial restoration with pyrroloquinoline quinone alleviates hypoxia, inflammation, and gut damage.
Kan Yu   +10 more
wiley   +1 more source

Glucose Modulates Macrophage Polarization By Glycating Adsorbed Albumin On Titanium

open access: yesInternational Dental Journal
Aim or purpose: Diabetes induces implant failure by macrophage M1-polarization, but whether high glucose modulates macrophage polarization via adsorbed protein is yet unknown.
Shuting Jiang, Yongbin Mou
doaj   +1 more source

CCL18 synergises with high concentrations of glucose in stimulating fibronectin production in human renal tubuloepithelial cells.

open access: yes, 2016
Background: Diabetic nephropathy is the leading cause of end stage kidney disease worldwide. The pathogenesis of this disease remains elusive and multiple factors have been implicated.
Bhangal, G   +4 more
core   +1 more source

Associations of obesity, systemic inflammation, and hyperinsulinemia with the incidence of non‐communicable chronic disease and mortality: A prospective cohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3883-3894, May 2026.
Abstract Aims Obesity, systemic inflammation, and hyperinsulinemia are all features of metabolic syndrome and frequently occur together. We aimed to evaluate the association of body mass index (BMI) with incident non‐communicable chronic disease (NCD) or all‐cause mortality, independent of C‐reactive protein (CRP) and fasting insulin.
Natasha Wiebe   +5 more
wiley   +1 more source

The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4335-4343, May 2026.
ABSTRACT Background Type 1 diabetes (T1D) and overweight/obesity (OW) are chronic conditions impairing health‐related quality of life (HRQoL). While diabetes primarily affects psychosocial domains, OW impacts physical functioning and social stigma. Despite the increasing prevalence of OW among individuals with T1D, their combined effect on HRQoL has ...
Renata Risi   +15 more
wiley   +1 more source

Risk Factors and Nomogram Model for Multidrug‐Resistant Bacterial Infections in Diabetic Foot Wounds

open access: yesInternational Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT To study the risk factors associated with multidrug‐resistant bacteria (MDRB) infection in diabetic foot (DF) wounds and to develop a nomogram model to predict the risk of MDRB infection in patients with DF. A total of 157 patients with DF between January 2013 and December 2023 were included in this study.
Guangzhe Meng   +8 more
wiley   +1 more source

Clinical Outcomes and Non‐Invasive Testing in Metabolic Dysfunction‐Associated Steatohepatitis With Cirrhosis: A Systematic Review

open access: yesLiver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatohepatitis (MASH) with cirrhosis lacks definitive treatments and poses an increasing healthcare burden globally. We undertook a systematic literature review (SLR) to better understand the disease burden in cirrhosis due to MASH.
Hannes Hagström   +8 more
wiley   +1 more source

Engineering Marker‐Free Lettuce Chloroplast Genome to Express Functional Glucagon‐Like Peptide‐1 Receptor Agonists Exenatide and Lixisenatide

open access: yesPlant Biotechnology Journal, Volume 24, Issue 5, Page 3158-3171, May 2026.
Engineering of marker‐free lettuce chloroplast genome to express CTB‐Exenatide and CTB‐Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification, refrigeration and invasive delivery methods.
Rahul Singh, Henry Daniell
wiley   +1 more source

Home - About - Disclaimer - Privacy